Intesity Therapeutics Inc (INTS)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -120.479 | -63.204 | -102.772 | -217.467 | -124.522 |
| Return on Equity (%) | 452.862 | 306.558 | 154.189 | 63.765 | 1226.047 |
| Return on Invested Capital (%) | -148.762 | -77.415 | -166.438 | 377.355 | -264.726 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 0.852 | 0.838 | 0.198 | -0.765 | 0.776 |
| Earnings Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.699 |
| Cash Per Share | 0.428 | 0.925 | 0.682 | 0.197 | 0.505 |
| Working Capital Per Share | 0.84 | 0.822 | 0.152 | -0.806 | 0.678 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.621 |
| EBITDA Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.621 |
| Free Cash Flow Per Share | -0.601 | -0.599 | -1.186 | -1.138 | -0.699 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 6.81M | 6.82M | 3.41M | 3.41M | N/A |
| Year End December 30 2023 | Dec 2021 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | 3.41M | 3.41M | N/A | N/A | N/A | N/A | N/A | 13.87M |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 32.17M |
| Price to Earnings Ratio | -2.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.7 |
| Price to Book Ratio | 2.4 |
| Dividend Yield | - |
| Shares Outstanding | 13.87M |
| Average Volume (1 week) | 33.08k |
| Average Volume (1 Month) | 37.78k |
| 52 Week Change | -42.71% |
| 52 Week High | 5.94 |
| 52 Week Low | 1.50 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
